KeViRx

KeViRx is an early stage drug discovery company whose mission is to advance new therapeutics to clinical testing.

[KeViRx @KeViRx1]

Here's a link to a short video about who we are and what we're up to at KeViRx: https://t.co/KFGLMgzkJ8 #CancerResearch #SmallBusiness #ChemicalBiology #DrugDiscovery #SmallMoleculeTherapeutics

[Rachel Rath @RachelRRath]

Welcome @KeViRx1 to #BLUEKNIGHT, a @JLABS & @BARDA initiative! Looking forward to having you as part of #JLABSDC and Blue Knight as you continue to advance your #smallmolecule platform to discover and develop therapeutics for acute lung injury and other indications.

[KeViRx @KeViRx1]

KeViRx has been selected to join Blue Knight, a JLABS and BARDA initiative designed to anticipate and respond to global health threats.
https://t.co/ZU7JdLsmLI

[Virginia Drug Discovery Consortium @Va_DrugDisc]

Congrats to VaDDC Exec Comm members Beth Sharlow, John Catravas, John Lazo! This SBIR is a perfect example of the multi-institutional translational drug development that VaDDC seeks to foster @KeViRx1 @MedicineUVA @ODU https://t.co/mupIE50tmJ

[KeViRx @KeViRx1]

High Protein Tyrosine Phosphatase 4A3 expression is correlated with poor #OvarianCancer patient prognosis. Small molecules are being used to inhibit this target and reduce ovarian cancer cell survival: https://t.co/7ITdsxmVXR via @MDPIOpenAccess

[KeViRx @KeViRx1]

KeViRx has a LinkedIn! You can follow us here: https://t.co/aw6x0sSbog